TRIUMF joins the Canadian Nuclear Isotope Council to strengthen national capacity in radioisotope and radiopharmaceutical research and education
TRIUMF and CNIC to work together to help further realize the benefits that medical isotopes bring in diagnosing and treating life-threatening illnesses, from cancer to dementia to cardiac disease. Vancouver, June 24, 2019 – TRIUMF, Canada’s particle accelerator centre, is pleased to announce that it has joined a growing list of Canadian organizations that are members of the Canadian Nuclear Isotope Council (CNIC).